BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02923180-completion@plaintrial.com
DTSTAMP:20261028T224712Z
DTSTART;VALUE=DATE:202607
SUMMARY:Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermedia
 te and High-Risk Prostate Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02923180
URL:https://plaintrial.com/trial/NCT02923180
END:VEVENT
END:VCALENDAR